The European Medicines Agency’s Committee for Medicinal Products for Human Use found that Leqembi’s benefits do not outweigh the risks of severe side effects associated with the treatment.
- Forums
- ASX - By Stock
- EU regulators reject Leqembi for Alzheimers
The European Medicines Agency’s Committee for Medicinal Products...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
-0.004(8.89%) |
Mkt cap ! $111.1M |
Open | High | Low | Value | Volume |
4.6¢ | 4.6¢ | 4.0¢ | $788.3K | 18.56M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 155092 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 198568 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 155092 | 0.041 |
24 | 3725384 | 0.040 |
5 | 271001 | 0.039 |
6 | 332540 | 0.038 |
4 | 1563526 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 198568 | 2 |
0.043 | 265430 | 3 |
0.044 | 779286 | 7 |
0.045 | 762091 | 8 |
0.046 | 845170 | 5 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |